344 related articles for article (PubMed ID: 29920340)
1. B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD).
Bruzzì S; Sutti S; Giudici G; Burlone ME; Ramavath NN; Toscani A; Bozzola C; Schneider P; Morello E; Parola M; Pirisi M; Albano E
Free Radic Biol Med; 2018 Aug; 124():249-259. PubMed ID: 29920340
[TBL] [Abstract][Full Text] [Related]
2. Adaptive immunity: an emerging player in the progression of NAFLD.
Sutti S; Albano E
Nat Rev Gastroenterol Hepatol; 2020 Feb; 17(2):81-92. PubMed ID: 31605031
[TBL] [Abstract][Full Text] [Related]
3. The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update.
Sutti S; Bruzzì S; Albano E
Expert Rev Gastroenterol Hepatol; 2016; 10(2):243-53. PubMed ID: 26634783
[TBL] [Abstract][Full Text] [Related]
4. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH.
Sutti S; Jindal A; Locatelli I; Vacchiano M; Gigliotti L; Bozzola C; Albano E
Hepatology; 2014 Mar; 59(3):886-97. PubMed ID: 24115128
[TBL] [Abstract][Full Text] [Related]
5. Microbiota-Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling.
Barrow F; Khan S; Fredrickson G; Wang H; Dietsche K; Parthiban P; Robert S; Kaiser T; Winer S; Herman A; Adeyi O; Mouzaki M; Khoruts A; Hogquist KA; Staley C; Winer DA; Revelo XS
Hepatology; 2021 Aug; 74(2):704-722. PubMed ID: 33609303
[TBL] [Abstract][Full Text] [Related]
6. Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease.
Hendrikx T; Watzenböck ML; Walenbergh SM; Amir S; Gruber S; Kozma MO; Grabsch HI; Koek GH; Pierik MJ; Staufer K; Trauner M; Kalhan SC; Jonkers D; Hofker MH; Binder CJ; Shiri-Sverdlov R
BMC Med; 2016 Jul; 14(1):107. PubMed ID: 27443391
[TBL] [Abstract][Full Text] [Related]
7. Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β.
Hart KM; Fabre T; Sciurba JC; Gieseck RL; Borthwick LA; Vannella KM; Acciani TH; de Queiroz Prado R; Thompson RW; White S; Soucy G; Bilodeau M; Ramalingam TR; Arron JR; Shoukry NH; Wynn TA
Sci Transl Med; 2017 Jun; 9(396):. PubMed ID: 28659437
[TBL] [Abstract][Full Text] [Related]
8. Role of intrahepatic B cells in non-alcoholic fatty liver disease by secreting pro-inflammatory cytokines and regulating intrahepatic T cells.
Zhang F; Jiang WW; Li X; Qiu XY; Wu Z; Chi YJ; Cong X; Liu YL
J Dig Dis; 2016 Jul; 17(7):464-74. PubMed ID: 27216040
[TBL] [Abstract][Full Text] [Related]
9. Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model.
Hu Y; Zhang H; Li J; Cong X; Chen Y; He G; Chi Y; Liu Y
J Gastroenterol Hepatol; 2016 Mar; 31(3):676-84. PubMed ID: 26430807
[TBL] [Abstract][Full Text] [Related]
10. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
[TBL] [Abstract][Full Text] [Related]
11. Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression.
Dallio M; Sangineto M; Romeo M; Villani R; Romano AD; Loguercio C; Serviddio G; Federico A
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33406763
[TBL] [Abstract][Full Text] [Related]
12. Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization.
Li Y; Huang B; Jiang X; Chen W; Zhang J; Wei Y; Chen Y; Lian M; Bian Z; Miao Q; Peng Y; Fang J; Wang Q; Tang R; Gershwin ME; Ma X
Front Immunol; 2018; 9():1994. PubMed ID: 30233587
[TBL] [Abstract][Full Text] [Related]
13. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
14. OX40 Regulates Both Innate and Adaptive Immunity and Promotes Nonalcoholic Steatohepatitis.
Sun G; Jin H; Zhang C; Meng H; Zhao X; Wei D; Ou X; Wang Q; Li S; Wang T; Sun X; Shi W; Tian D; Liu K; Xu H; Tian Y; Li X; Guo W; Jia J; Zhang Z; Zhang D
Cell Rep; 2018 Dec; 25(13):3786-3799.e4. PubMed ID: 30590049
[TBL] [Abstract][Full Text] [Related]
15. CD4
Her Z; Tan JHL; Lim YS; Tan SY; Chan XY; Tan WWS; Liu M; Yong KSM; Lai F; Ceccarello E; Zheng Z; Fan Y; Chang KTE; Sun L; Chang SC; Chin CL; Lee GH; Dan YY; Chan YS; Lim SG; Chan JKY; Chandy KG; Chen Q
Front Immunol; 2020; 11():580968. PubMed ID: 33013934
[TBL] [Abstract][Full Text] [Related]
16. Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis.
Maricic I; Marrero I; Eguchi A; Nakamura R; Johnson CD; Dasgupta S; Hernandez CD; Nguyen PS; Swafford AD; Knight R; Feldstein AE; Loomba R; Kumar V
J Immunol; 2018 Nov; 201(10):3017-3035. PubMed ID: 30322964
[TBL] [Abstract][Full Text] [Related]
17. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
18. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.
Ma C; Kesarwala AH; Eggert T; Medina-Echeverz J; Kleiner DE; Jin P; Stroncek DF; Terabe M; Kapoor V; ElGindi M; Han M; Thornton AM; Zhang H; Egger M; Luo J; Felsher DW; McVicar DW; Weber A; Heikenwalder M; Greten TF
Nature; 2016 Mar; 531(7593):253-7. PubMed ID: 26934227
[TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non‑alcoholic fatty liver disease mouse model.
Lu Y; Lin Y; Huang X; Wu S; Wei J; Yang C
Int J Mol Med; 2019 Jun; 43(6):2398-2408. PubMed ID: 30942432
[TBL] [Abstract][Full Text] [Related]
20. NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicity.
Alhasson F; Dattaroy D; Das S; Chandrashekaran V; Seth RK; Schnellmann RG; Chatterjee S
Am J Physiol Renal Physiol; 2016 Jan; 310(1):F85-F101. PubMed ID: 26447219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
